共 49 条
- [41] A Phase 3, randomized, placebo-controlled, 12-week, double-blind study, plus a non-controlled extension treatment period, to assess efficacy and safety of fezolinetant, a neurokin-3 receptor antagonist, in women with moderate-to-severe vasomotor symptoms associated with menopause MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (12): : 1450 - 1450
- [43] THE EFFECTS OF A 12-WEEK'S COMBINED EXERCISE INTERVENTION ON PHYSICAL FUNCTION AND MENTAL HEALTH AFTER RADICAL PROSTATECTOMY IN ELDERLY PATIENTS WITH PROSTATE CANCER: A PROSPECTIVE, RANDOMIZED CONTROLLED STUDY JOURNAL OF UROLOGY, 2011, 185 (04): : E524 - E524
- [46] Dairy Food Consumption and Meal-Induced Cortisol Response Interacted to Influence Weight Loss in Overweight Women Undergoing a 12-Week, Meal-Controlled, Weight Loss Intervention JOURNAL OF NUTRITION, 2013, 143 (01): : 46 - 52
- [47] A 12-week consumer wearable activity tracker-based intervention reduces sedentary behaviour and improves cardiometabolic health in free-living sedentary adults: a randomised controlled trial Journal of Activity, Sedentary and Sleep Behaviors, 1 (1):